Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial.
Saved in:
| Title: | Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial. |
|---|---|
| Authors: | Macarulla T; Vall d'Hebron University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain., Ren Z; Department of Hepatic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China., Chon HJ; CHA Bundang Medical Center, Seongnam-Si, South Korea., Park JO; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Kim JW; Seoul National University Bundang Hospital, Seongnam, South Korea., Pressiani T; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Li D; City of Hope National Comprehensive Cancer Center, Duarte, CA., Zhukova L; SBIH 'Moscow Clinical Scientific and Practical Center Named After A.S. Loginov' DHM, Moscow, Russian Federation., Zhu AX; Jiahui International Cancer Center, Jiahui Health, Shanghai, China., Chen MH; Taipei Veterans General Hospital, Taipei, Taiwan., Hack SP; Genentech Inc, South San Francisco, CA., Wu S; Genentech Inc, South San Francisco, CA., Liu B; Genentech Inc, South San Francisco, CA., Guan X; Genentech Inc, South San Francisco, CA., Lu S; Genentech Inc, South San Francisco, CA., Wang Y; Genentech Inc, South San Francisco, CA., El-Khoueiry AB; USC Norris Comprehensive Cancer Center, Los Angeles, CA. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Feb 10; Vol. 43 (5), pp. 545-557. Date of Electronic Publication: 2024 Oct 18. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39423355 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Macarulla+T%22">Macarulla T</searchLink>; Vall d'Hebron University Hospital, Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ren+Z%22">Ren Z</searchLink>; Department of Hepatic Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Chon+HJ%22">Chon HJ</searchLink>; CHA Bundang Medical Center, Seongnam-Si, South Korea.<br /><searchLink fieldCode="AU" term="%22Park+JO%22">Park JO</searchLink>; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JW%22">Kim JW</searchLink>; Seoul National University Bundang Hospital, Seongnam, South Korea.<br /><searchLink fieldCode="AU" term="%22Pressiani+T%22">Pressiani T</searchLink>; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Li+D%22">Li D</searchLink>; City of Hope National Comprehensive Cancer Center, Duarte, CA.<br /><searchLink fieldCode="AU" term="%22Zhukova+L%22">Zhukova L</searchLink>; SBIH 'Moscow Clinical Scientific and Practical Center Named After A.S. Loginov' DHM, Moscow, Russian Federation.<br /><searchLink fieldCode="AU" term="%22Zhu+AX%22">Zhu AX</searchLink>; Jiahui International Cancer Center, Jiahui Health, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Chen+MH%22">Chen MH</searchLink>; Taipei Veterans General Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hack+SP%22">Hack SP</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Wu+S%22">Wu S</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Liu+B%22">Liu B</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Guan+X%22">Guan X</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Lu+S%22">Lu S</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Genentech Inc, South San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22El-Khoueiry+AB%22">El-Khoueiry AB</searchLink>; USC Norris Comprehensive Cancer Center, Los Angeles, CA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2025 Feb 10; Vol. 43 (5), pp. 545-557. <i>Date of Electronic Publication: </i>2024 Oct 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39423355 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/JCO.24.00337 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 545 Titles: – TitleFull: Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Macarulla T – PersonEntity: Name: NameFull: Ren Z – PersonEntity: Name: NameFull: Chon HJ – PersonEntity: Name: NameFull: Park JO – PersonEntity: Name: NameFull: Kim JW – PersonEntity: Name: NameFull: Pressiani T – PersonEntity: Name: NameFull: Li D – PersonEntity: Name: NameFull: Zhukova L – PersonEntity: Name: NameFull: Zhu AX – PersonEntity: Name: NameFull: Chen MH – PersonEntity: Name: NameFull: Hack SP – PersonEntity: Name: NameFull: Wu S – PersonEntity: Name: NameFull: Liu B – PersonEntity: Name: NameFull: Guan X – PersonEntity: Name: NameFull: Lu S – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: El-Khoueiry AB IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 02 Text: 2025 Feb 10 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1527-7755 Numbering: – Type: volume Value: 43 – Type: issue Value: 5 Titles: – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology Type: main |
| ResultId | 1 |